Brind.

Abbott Laboratories and Roche are key players in the Kenyan IVD market.

1 report, 1 independent Updated Jul 21

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Hoffmann-La Roche Abbott Laboratories

Keep exploring

The entities involved

Hoffmann-La Roche
Swiss healthcare company
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
- Hoffmann-La Roche opened a new R&D center in Boston.Sat 11:08
Abbott Laboratories
American global health care and medical device products company
- MarketBeat listed Abbott, Eli Lilly, Pfizer, Gilead, AbbVie, and McKesson as stocks to watch on June 7, 2026.Sun 18:28
- Trump's pledge to unleash oil and gas is reported to benefit stocks, involving Erie Indemnity.Sun 07:04

Coverage

Newest first; wire copies grouped

Jul 21GlobeNewswireKenya IVD Market Research Report 2025-2032 | Opportunities in Increasing Adoption of Self-testing Kits, Emerging Technologies, Shift Towards Personalized Medicine, Integration of Digital Health The K